Back to Michigan

HB5941 • 2026

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Karl Bohnak (District 109)
Last action
2026-05-13
Official status
bill electronically reproduced 05/12/2026
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department.

What This Bill Does

  • Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department.
  • Creates new act.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-05-13 HJ 36 Pg. 0

    bill electronically reproduced 05/12/2026

  2. 2026-05-12 HJ 35 Pg. 0

    introduced by Representative Rep. Karl Bohnak

  3. 2026-05-12 HJ 35 Pg. 0

    read a first time

  4. 2026-05-12 HJ 35 Pg. 0

    referred to Committee on Health Policy

Official Summary Text

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.